PA
SIBN icon

PharVision Advisers’s SI-BONE Inc SIBN Stock Holding History

PharVision Advisers’s Portfolio SIBN Stock Details SIBN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,318
Closed -$361K – 561
2025
Q4 		$361K Sell
18,318
-10,981
-37% -$191K 0.18% 165
2025
Q3 		$431K Buy
+29,299
New +$478K 0.24% 52

Other funds holding SIBN

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

PharVision Advisers's SIBN Position: Q1 2026 in Review

PharVision Advisers sold out of SI-BONE Inc (SIBN) in Q1 2026, closing a stake of 18,318 shares — an estimated $361K sold.

PharVision Advisers first reported a position in SIBN in Q3 2025 and held it in 2 quarters. The position peaked at $431K in Q3 2025. 180 funds tracked by Wall St. Rank hold SIBN as of Q1 2026.

  • PharVision Advisers reported no remaining SI-BONE Inc position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 18,318 SI-BONE Inc shares in Q1 2026, an estimated $361K.
  • PharVision Advisers first reported a position in SI-BONE Inc in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's SI-BONE Inc position peaked at $431K in Q3 2025.
  • 180 funds tracked by Wall St. Rank held SI-BONE Inc as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.